However, a tendency was observed for a shorter PFS in patients with an ELMO3 hypomethylated tumor (Hazard ratio; 1.48, 95% confidence interval; 0.89–2.47, p = 0.129). The gene discussed is ELMO3; the disease is neoplasm.